The study is a prospective clinical cohort study of consecutive patients hospitalized at all hospitals of greater Copenhagen with a laboratory confirmed diagnosis of COVID-19. The investigators aim to examine if continuous ECG monitoring can be used to understand the contribution of COVID-19 infection in the acute phase to the development of cardiac arrhythmias, especially focusing on cardiovascular outcomes. In all patients included, the investigators aim to examine if continuous ECG monitoring - alone and in combination with biomarkers - can be used to detect early signs of cardiac complications and predict long-term risk of cardiovascular morbidity and mortality following COVID-19 infection.
Study Type
OBSERVATIONAL
Enrollment
1,000
ECG monitoring
Department of Cardiology, Herlev & Gentofte Hospital
Copenhagen, Hellerup, Denmark
In-hospital mortality during hospitalization and a confirmed COVID-19 diagnosis
Time frame: 4 months
Incident intensive care unit admission during hospitalization and a confirmed COVID-19 diagnosis
Time frame: 4 months
Incident pulmonary embolism during hospitalization and a confirmed COVID-19 diagnosis
Time frame: 4 months
Incident cardiac arrest during hospitalization and a confirmed COVID-19 diagnosis
Time frame: 4 months
Incident hypoxic respiratory failure during hospitalization and a confirmed COVID-19 diagnosis
Time frame: 4 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.